These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11270778)

  • 1. Shared genetic risk factors in autoimmune liver disease.
    Czaja AJ; Santrach PJ; Breanndan Moore S
    Dig Dis Sci; 2001 Jan; 46(1):140-7. PubMed ID: 11270778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives.
    Wang P; Su H; Underhill J; Blackmore LJ; Longhi MS; Grammatikopoulos T; Okokon EV; Davies ET; Vergani D; Mieli-Vergani G; Ma Y
    J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):457-62. PubMed ID: 24231645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
    Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
    Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of primary sclerosing cholangitis with HLA-DRw52a.
    Prochazka EJ; Terasaki PI; Park MS; Goldstein LI; Busuttil RW
    N Engl J Med; 1990 Jun; 322(26):1842-4. PubMed ID: 2348837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of autoimmune liver disease.
    Feld JJ; Heathcote EJ
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1118-28. PubMed ID: 12974897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into autoimmune liver diseases provided by genome-wide association studies.
    Mells GF; Kaser A; Karlsen TH
    J Autoimmun; 2013 Oct; 46():41-54. PubMed ID: 23931959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Risk and the Development of Autoimmune Liver Disease.
    Karlsen TH; Chung BK
    Dig Dis; 2015; 33 Suppl 2():13-24. PubMed ID: 26641277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmune hepatitis and overlap syndrome: therapy].
    Löhr HF
    Praxis (Bern 1994); 2002 Aug; 91(34):1347-51. PubMed ID: 12233265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective.
    Kingham JG; Abbasi A
    Eur J Gastroenterol Hepatol; 2005 Oct; 17(10):1077-80. PubMed ID: 16148553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
    Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
    Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How genetic risk contributes to autoimmune liver disease.
    Ellinghaus D
    Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings.
    Habior A; Rawa T; Orłowska J; Sankowska M; Lewartowska A; Tilszer A; Pawlak J; Krawczyk M; Butruk E
    Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):787-91. PubMed ID: 12169991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using GWAS to identify genetic predisposition in hepatic autoimmunity.
    Webb GJ; Hirschfield GM
    J Autoimmun; 2016 Jan; 66():25-39. PubMed ID: 26347073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQ associations in type 1 autoimmune hepatitis.
    Czaja AJ; Santrach PJ; Moore SB
    Mayo Clin Proc; 1995 Dec; 70(12):1154-60. PubMed ID: 7490916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1?
    Coss Adame E; Granados J; Uribe M; Torre A
    Ann Hepatol; 2011; 10(1):28-32. PubMed ID: 21301006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT
    Am J Gastroenterol; 2002 Aug; 97(8):2051-7. PubMed ID: 12190176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.
    Mehal WZ; Lo YM; Wordsworth BP; Neuberger JM; Hubscher SC; Fleming KA; Chapman RW
    Gastroenterology; 1994 Jan; 106(1):160-7. PubMed ID: 8276178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune liver disease, autoimmunity and liver transplantation.
    Carbone M; Neuberger JM
    J Hepatol; 2014 Jan; 60(1):210-23. PubMed ID: 24084655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis.
    Broomé U; Scheynius A; Hultcrantz R
    Hepatology; 1993 Aug; 18(2):298-303. PubMed ID: 8340058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor alpha (TNF-α) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis.
    Li S; Huang X; Zhong H; Chen Z; Peng Q; Deng Y; Qin X
    J Genet; 2013 Dec; 92(3):617-28. PubMed ID: 24371186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.